Pfizer Inc said on Friday the Covid-19 pandemic could extend through next year and announced plans to develop a three-dose vaccine regimen for children ages 2 to 16, a move that could delay its authorisation.
AMWAJ Real Estate
Pfizer Inc said on Friday the Covid-19 pandemic could extend through next year and announced plans to develop a three-dose vaccine regimen for children ages 2 to 16, a move that could delay its authorisation.